发明名称 Enhanced drug delivery in transdermal systems
摘要 Disclosed are compositions for the transdermal delivery of drugs, comprising a therapeutically effective amount of a drug that includes a parent drug and a prodrug, wherein (a) the parent drug is selected from ACE inhibitors, anabolic steroids, androgenic steroids, glucocorticoids, mineral corticoids, progestins, and estrogens, or (b) the parent drug is estradiol and the prodrug is an estradiol derivative. Also disclosed is a method of suppressing crystal formation of a steroid in a transdermal drug delivery system, comprising combining two or more corresponding derivatives of the steroid in a pressure-sensitive adhesive carrier composition.
申请公布号 NZ530227(A) 申请公布日期 2006.09.29
申请号 NZ20020530227 申请日期 2002.06.18
申请人 NOVEN PHARMACEUTICALS, INC 发明人 HOUZE, DAVID;NGUYEN, VIET
分类号 A61K9/00;A61K9/70;A61K31/403;A61K31/56;A61K31/565;A61K31/567;A61K31/5685;A61K31/57;A61K31/573;A61K38/55;A61K45/00;A61K45/06;A61K47/10;A61K47/12;A61K47/32;A61K47/34;A61K47/48;A61P5/26;A61P5/30;A61P9/12;A61P43/00;(IPC1-7):A61K31/56;A61K31/55;A61K31/415;A61K31/40 主分类号 A61K9/00
代理机构 代理人
主权项
地址